Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B LIPTON

Showing results (1041-1050 of 1,306) with videos related to

Pageof 131
Sort By:
Contemporary Clinical Trials|March 26, 2013
Can weight loss improve migraine headaches in obese women? Rationale and design of the Women's Health and Migraine (WHAM) randomized controlled trialDale S Bond, Kevin C O'Leary, J Graham Thomas, et al.
Neurology|November 7, 2019
Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO StudyRichard B Lipton, Kristina M Fanning, Dawn C Buse, et al.
The Journal of Headache and Pain|March 4, 2020
Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) studyDawn C Buse, Michael L Reed, Kristina M Fanning, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 6, 2021
Predictive value of ATN biomarker profiles in estimating disease progression in Alzheimer's disease dementiaAli Ezzati, Ahmed Abdulkadir, Clifford R Jack, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsCuiling Wang, Qi Gao, Katherine H Chang, et al.
Headache|January 7, 2026
Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME (US) studyJessica Ailani, Rose Okonkwo, Elizabeth Johnston, et al.
Journal of Neurology|August 24, 2023
Risk factors for migraine disease progression: a narrative review for a patient-centered approachRichard B Lipton, Dawn C Buse, Stephanie J Nahas, et al.
Cephalalgia : an International Journal of Headache|January 10, 2022
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trialUmer Najib, Timothy Smith, Nada Hindiyeh, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 20, 2010
Clinical expression of LRRK2 G2019S mutations in the elderlyMarta San Luciano, Richard B Lipton, Cuiling Wang, et al.
Archives of Neurology|September 1, 1987
Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancerR B Lipton, B S Galer, J P Dutcher, et al.
Pageof 131

Showing results (1041-1050 of 1,306) with videos related to

Sort By:
Pageof 131
Contemporary Clinical Trials|March 26, 2013
Can weight loss improve migraine headaches in obese women? Rationale and design of the Women's Health and Migraine (WHAM) randomized controlled trialDale S Bond, Kevin C O'Leary, J Graham Thomas, et al.
Neurology|November 7, 2019
Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO StudyRichard B Lipton, Kristina M Fanning, Dawn C Buse, et al.
The Journal of Headache and Pain|March 4, 2020
Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) studyDawn C Buse, Michael L Reed, Kristina M Fanning, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 6, 2021
Predictive value of ATN biomarker profiles in estimating disease progression in Alzheimer's disease dementiaAli Ezzati, Ahmed Abdulkadir, Clifford R Jack, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsCuiling Wang, Qi Gao, Katherine H Chang, et al.
Headache|January 7, 2026
Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME (US) studyJessica Ailani, Rose Okonkwo, Elizabeth Johnston, et al.
Journal of Neurology|August 24, 2023
Risk factors for migraine disease progression: a narrative review for a patient-centered approachRichard B Lipton, Dawn C Buse, Stephanie J Nahas, et al.
Cephalalgia : an International Journal of Headache|January 10, 2022
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trialUmer Najib, Timothy Smith, Nada Hindiyeh, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 20, 2010
Clinical expression of LRRK2 G2019S mutations in the elderlyMarta San Luciano, Richard B Lipton, Cuiling Wang, et al.
Archives of Neurology|September 1, 1987
Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancerR B Lipton, B S Galer, J P Dutcher, et al.
Pageof 131